Patent | Date |
---|
Antibodies and methods of use thereof Grant 11,447,557 - Wilson , et al. September 20, 2 | 2022-09-20 |
Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors Grant 11,426,460 - Deng , et al. August 30, 2 | 2022-08-30 |
Anti-ctla-4 Antibodies And Methods Of Use Thereof App 20220267443 - Van DIJK; Marc ;   et al. | 2022-08-25 |
Anti-GITR antibodies and methods of use thereof Grant 11,401,335 - Gonzalez , et al. August 2, 2 | 2022-08-02 |
Use Of Mva Or Mvadeltae3l As Immunotherapeutic Agents Against Solid Tumors App 20220211785 - DENG; Liang ;   et al. | 2022-07-07 |
Vaccinia Virus Mutants Useful For Cancer Immunotherapy App 20220186192 - Deng; Liang ;   et al. | 2022-06-16 |
Anti-OX40 antibodies and anti-GITR antibodies Grant 11,359,028 - Wilson , et al. June 14, 2 | 2022-06-14 |
Anti-PD-1 antibodies and methods of use thereof Grant 11,345,755 - Van Dijk , et al. May 31, 2 | 2022-05-31 |
Vectors comprising nucleic acids encoding anti-OX40 antibodies Grant 11,332,536 - Van Dijk , et al. May 17, 2 | 2022-05-17 |
Anti-ox40 Antibodies And Methods Of Use Thereof App 20220098316 - VAN DIJK; Marc ;   et al. | 2022-03-31 |
Recombinant MVA or MVA.DELTA.E3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors Grant 11,285,209 - Deng , et al. March 29, 2 | 2022-03-29 |
Anti-CTLA-4 antibodies and methods of use thereof Grant 11,267,889 - Van Dijk , et al. March 8, 2 | 2022-03-08 |
Recombinant Poxviruses For Cancer Immunotherapy App 20220056475 - DENG; Liang ;   et al. | 2022-02-24 |
Use of MVA or MVA.DELTA.E3L as immunotherapeutic agents against solid tumors Grant 11,253,560 - Deng , et al. February 22, 2 | 2022-02-22 |
Vaccinia virus mutants useful for cancer immunotherapy Grant 11,242,509 - Deng , et al. February 8, 2 | 2022-02-08 |
Anti-ox40 Antibodies And Methods Of Use Thereof App 20210324097 - WILSON; Nicholas S. ;   et al. | 2021-10-21 |
Anti-OX40 antibodies Grant 11,136,404 - Van Dijk , et al. October 5, 2 | 2021-10-05 |
Anti-ctla-4 Antibodies And Methods Of Use Thereof App 20210205451 - van Dijk; Marc ;   et al. | 2021-07-08 |
Inhibition of CTLA-4 and/or PD-1 For Regulation of T Cells App 20210179714 - WOLCHOK; Jedd ;   et al. | 2021-06-17 |
Heat-inactivated Vaccinia Virus As A Vaccine Immune Adjuvant App 20210177964 - DENG; Liang ;   et al. | 2021-06-17 |
Antibodies And Methods Of Use Thereof App 20210171648 - WILSON; Nicholas S. ;   et al. | 2021-06-10 |
Anti-CTLA-4 antibodies and methods of use thereof Grant 11,013,802 - van Dijk , et al. May 25, 2 | 2021-05-25 |
Anti-gitr Antibodies And Methods Of Use Thereof App 20210070872 - SEIBERT; Volker ;   et al. | 2021-03-11 |
Anti-CTLA-4 antibodies and methods of use thereof Grant 10,912,831 - van Dijk , et al. February 9, 2 | 2021-02-09 |
Oncolytic Vaccinia Virus Expressing Immune Checkpoint Blockade For Cancer Immunotherapy App 20210023151 - DENG; Liang ;   et al. | 2021-01-28 |
Anti-ctla-4 Antibodies And Methods Of Use Thereof App 20210023214 - van Dijk; Marc ;   et al. | 2021-01-28 |
Antibodies and methods of use thereof Grant 10,836,830 - Wilson , et al. November 17, 2 | 2020-11-17 |
Anti-ctla-4 Antibodies And Methods Of Use Thereof App 20200354455 - VAN DIJK; Marc ;   et al. | 2020-11-12 |
Anti-pd-1 Antibodies And Methods Of Use Thereof App 20200354454 - VAN DIJK; Marc ;   et al. | 2020-11-12 |
Anti-GITR antibodies and methods of use thereof Grant 10,829,559 - Seibert , et al. November 10, 2 | 2020-11-10 |
Anti-gitr Antibodies And Methods Of Use Thereof App 20200339698 - GONZALEZ; Ana M. ;   et al. | 2020-10-29 |
Anti-GITR antibodies and methods of use thereof Grant 10,800,849 - Gonzalez , et al. October 13, 2 | 2020-10-13 |
Antibodies And Methods Of Use Thereof App 20200317797 - WILSON; Nicholas S. ;   et al. | 2020-10-08 |
Anti-ox40 Antibodies And Methods Of Use Thereof App 20200317796 - VAN DIJK; Marc ;   et al. | 2020-10-08 |
Recombinant Mva Or Mvadele3l Expressing Human Flt3l And Use Thereof As Immuno-therapeutic Agents Against Solid Tumors App 20200316198 - DENG; Liang ;   et al. | 2020-10-08 |
Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human FLT3L or GM-CSF for cancer immunotherapy Grant 10,765,711 - Deng , et al. Sep | 2020-09-08 |
Anti-ox40 Antibodies And Methods Of Use Thereof App 20200270356 - VAN DIJK; Marc ;   et al. | 2020-08-27 |
Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors Grant 10,736,962 - Deng , et al. A | 2020-08-11 |
Replication Competent Attenuated Vaccinia Viruses With Deletion Of Thymidine Kinase With And Without The Expression Of Human Flt App 20200237839 - DENG; Liang ;   et al. | 2020-07-30 |
Use Of Inactivated Nonreplicating Modified Vaccinia Virus Ankara (mva) As Monoimmunotherapy Or In Combination With Immume Checkp App 20200237902 - Deng; Liang ;   et al. | 2020-07-30 |
Neoantigens And Uses Thereof For Treating Cancer App 20200232040 - Luksza; Marta ;   et al. | 2020-07-23 |
Use Of Mva Or Mvadeltae3l As Immunotherapeutic Agents Against Solid Tumors App 20200222479 - DENG; Liang ;   et al. | 2020-07-16 |
Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors Grant 10,639,366 - Deng , et al. | 2020-05-05 |
Anti-gitr Antibodies And Methods Of Use Thereof App 20200123265 - WILSON; Nicholas S. ;   et al. | 2020-04-23 |
Nucleic acids encoding anti-OX40 antibodies Grant 10,626,181 - Van Dijk , et al. | 2020-04-21 |
Alphavirus Replicon Particles Expressing TRP2 App 20200113984 - WOLCHOK; Jedd D. ;   et al. | 2020-04-16 |
Anti-ox40 Antibodies And Methods Of Use Thereof App 20200079862 - WILSON; Nicholas S. ;   et al. | 2020-03-12 |
Antibodies And Methods Of Use Thereof App 20200079861 - WILSON; Nicholas S. ;   et al. | 2020-03-12 |
Methods And Compositions For Tumor Therapy App 20200079860 - Khalil; Danny Nejad ;   et al. | 2020-03-12 |
Anti-GITR antibodies and methods of use thereof Grant 10,577,426 - Gonzalez , et al. | 2020-03-03 |
Bi-specific Activators For Tumor Therapy App 20200055947 - Khalil; Danny Nejad ;   et al. | 2020-02-20 |
Use of MVA or MVA.DELTA.E3L as immunotherapeutic agents against solid tumors Grant 10,548,930 - Deng , et al. Fe | 2020-02-04 |
Antibodies And Methods Of Use Thereof App 20200024350 - VAN DIJK; Marc ;   et al. | 2020-01-23 |
Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy Grant 10,512,662 - Deng , et al. Dec | 2019-12-24 |
Antigen-binding Proteins Targeting Melanoma Differentiation Antigens And Uses Thereof App 20190375855 - Merghoub; Taha ;   et al. | 2019-12-12 |
Anti-ox40 Antibodies, Anti-gitr Antibodies, And Methods Of Use Thereof App 20190367627 - WILSON; Nicholas S. ;   et al. | 2019-12-05 |
Anti-ox40 Antibodies And Methods Of Use Thereof App 20190352410 - VAN DIJK; Marc ;   et al. | 2019-11-21 |
Anti-CTLA-4 antibodies and methods of use thereof Grant 10,479,833 - van Dijk , et al. Nov | 2019-11-19 |
Anti-PD-1 antibodies and methods of use thereof Grant 10,450,373 - Van Dijk , et al. Oc | 2019-10-22 |
Anti-gitr Antibodies And Methods Of Use Thereof App 20190309082 - SEIBERT; Volker ;   et al. | 2019-10-10 |
Anti-ox40 Antibodies And Methods Of Use Thereof App 20190284291 - VAN DIJK; Marc ;   et al. | 2019-09-19 |
Anti-pd-1 Antibodies And Methods Of Use Thereof App 20190256601 - VAN DIJK; MARC ;   et al. | 2019-08-22 |
Anti-PD-1 antibodies and methods of use thereof Grant 10,323,091 - van Dijk , et al. | 2019-06-18 |
Anti-ctla-4 Antibodies And Methods Of Use Thereof App 20190135919 - van Dijk; Marc ;   et al. | 2019-05-09 |
Anti-GITR antibodies and methods of use thereof Grant 10,280,226 - Seibert , et al. | 2019-05-07 |
Anti-OX40 antibodies Grant 10,259,882 - Van Dijk , et al. | 2019-04-16 |
Anti-GITR Antibodies and Methods of Use Thereof App 20190062446 - SEIBERT; Volker ;   et al. | 2019-02-28 |
Replication Competent Attenuated Vaccinia Viruses With Deletion Of Thymidine Kinase With And Without The Expression Of Human Flt3l Or Gm-csf For Cancer Immunotherapy App 20190054131 - DENG; Liang ;   et al. | 2019-02-21 |
Recombinant Mva Or Mvadele3l Expressing Human Flt3l And Use Thereof As Immuno-therapeutic Agents Against Solid Tumors App 20190046640 - DENG; Liang ;   et al. | 2019-02-14 |
Anti-GITR Antibodies and Methods of Use Thereof App 20190010239 - GONZALEZ; Ana M. ;   et al. | 2019-01-10 |
Anti-GITR antibodies and methods of use thereof Grant 10,155,818 - Seibert , et al. Dec | 2018-12-18 |
Anti-GITR Antibodies and Methods of Use Thereof App 20180355051 - GONZALEZ; Ana M. ;   et al. | 2018-12-13 |
Anti-CTLA-4 antibodies and methods of use thereof Grant 10,144,779 - van Dijk , et al. De | 2018-12-04 |
Anti-GITR Antibodies and Methods of Use Thereof App 20180244793 - GONZALEZ; Ana M. ;   et al. | 2018-08-30 |
Use Of Inactivated Nonreplicating Modified Vaccinia Virus Ankara (mva) As Monoimmunotherapy Or In Combination With Immume Checkpoint Blocking Agents For Solid Tumors App 20180236062 - Deng; Liang ;   et al. | 2018-08-23 |
Anti-ctla-4 Antibodies And Methods Of Use Thereof App 20180185481 - van Dijk; Marc ;   et al. | 2018-07-05 |
Use Of Mva Or Mvadeltae3l As Immunotherapeutic Agents Against Solid Tumors App 20180078591 - DENG; Liang ;   et al. | 2018-03-22 |
Anti-pd-1 Antibodies And Methods Of Use Thereof App 20170081409 - Dijk; Marc van ;   et al. | 2017-03-23 |
Anti-ctla-4 Antibodies And Methods Of Use Thereof App 20160368989 - Dijk; Marc van ;   et al. | 2016-12-22 |
Anti-OX40 Antibodies and Methods of Use Thereof App 20160347847 - VAN DIJK; Marc ;   et al. | 2016-12-01 |
Anti-GITR Antibodies and Methods of Use Thereof App 20150368349 - GONZALEZ; Ana M. ;   et al. | 2015-12-24 |